Sales rise 10.65% to Rs 642.75 crore
Net profit of Alembic Pharmaceuticals declined 33.21% to Rs 59.24 crore in the quarter ended March 2017 as against Rs 88.70 crore during the previous quarter ended March 2016. Sales rose 10.65% to Rs 642.75 crore in the quarter ended March 2017 as against Rs 580.87 crore during the previous quarter ended March 2016.For the full year,net profit declined 38.37% to Rs 430.63 crore in the year ended March 2017 as against Rs 698.74 crore during the previous year ended March 2016. Sales declined 0.32% to Rs 2953.16 crore in the year ended March 2017 as against Rs 2962.65 crore during the previous year ended March 2016.
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales642.75580.87 11 2953.162962.65 0 OPM %15.3323.91 -21.4433.17 - PBDT98.15140.72 -30 632.61985.88 -36 PBT76.32116.60 -35 549.71914.02 -40 NP59.2488.70 -33 430.63698.74 -38
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
